EUVIMEDEUVIMED entdecken
FallberichtOpen Access

Drug‐induced hemolytic anemia due to ceftriaxone in a patient with recently identified alloantibodies: A diagnostic challenge

Kavya Balusu iD, Syed-Usman Ehsanullah, Jennifer Olejniczak, Kathleen Bensing, Tina Pugh, Kathleen Puca, Jacquelyn Choate

Transfusion · 2026-07 · 66 (7) · 1444-1448

DOI: 10.1111/trf.70222 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Transfusion, online erschienen am 10.04.2026. Verfasst von Kavya Balusu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Rochester General Hospital, Rochester, New York, USA. Hauptthemen laut MEDLINE: Isoantibodies, Anemia, Hemolytic, Ceftriaxone, Anti-Bacterial Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 11 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Drug‐induced immune hemolytic anemia (DIIHA) is a rare but potentially life‐threatening condition resulting from destruction of red blood cells (RBCs) following drug exposure. Although the precise incidence is difficult to ascertain because of under‐diagnosis and under‐reporting, estimates suggest an annual incidence of 1 in 1 million. This may be because often only patients with dramatic or severe hemolysis typically undergo comprehensive immunohematologic evaluation, including diagnostic drug testing. In patients receiving blood transfusions, making a diagnosis can be even more challenging as hemolysis may be complicated by concurrent alloimmunization. Case Report We present the case of a 51‐year‐old female with recently identified anti‐E and anti‐M alloantibodies who developed severe hemolytic anemia 3 days after blood transfusion, ultimately leading to multi‐organ failure and death. Although initially suspected to be due to a delayed hemolytic transfusion reaction, further immunohematology testing confirmed ceftriaxone‐induced immune hemolytic anemia.

Conclusion

This case highlights how DIIHA can be masquerading as a delayed hemolytic transfusion reaction, underscoring the importance of considering DIIHA as a differential diagnosis, especially in patients receiving commonly implicated drugs, so that they can be promptly discontinued to avoid adverse outcomes. Confirmatory testing can be done and is usually available at an immunohematology reference laboratory.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IsoantibodiesAnemia, HemolyticCeftriaxoneAnti-Bacterial AgentsAnemia, Hemolytic, AutoimmuneHumansFemaleMiddle AgedFatal Outcome

Stichwörter der Autor:innen

ceftriaxonedrug induced immune hemolytic anemiaimmunohematology

Substanzen

IsoantibodiesCeftriaxoneAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Internal Medicine, Rochester General Hospital, Rochester, New York, USA.
  • Department of Hematology/Oncology, Rochester General Hospital, Rochester, New York, USA.
  • Department of Transfusion Medicine, Rochester General Hospital, Rochester, New York, USA.
  • Immunohematology Reference Laboratory, Versiti Blood Center of Wisconsin, Milwaukee, Wisconsin, USA.

ORCID-Profile: Kavya Balusu

Zitieren

APA

Balusu, K., Ehsanullah, S. U., Olejniczak, J., Bensing, K., Pugh, T., Puca, K., & Choate, J. (2026). Drug‐induced hemolytic anemia due to ceftriaxone in a patient with recently identified alloantibodies: A diagnostic challenge. Transfusion, 66(7), 1444-1448. https://doi.org/10.1111/trf.70222

Vancouver

Balusu K, Ehsanullah SU, Olejniczak J, Bensing K, Pugh T, Puca K, et al. Drug‐induced hemolytic anemia due to ceftriaxone in a patient with recently identified alloantibodies: A diagnostic challenge. Transfusion. 2026;66(7):1444-1448. doi:10.1111/trf.70222

BibTeX
@article{Balusu2026,
  author = {Balusu, Kavya and Ehsanullah, Syed-Usman and Olejniczak, Jennifer and Bensing, Kathleen and Pugh, Tina and Puca, Kathleen and Choate, Jacquelyn},
  title = {Drug‐induced hemolytic anemia due to ceftriaxone in a patient with recently identified alloantibodies: A diagnostic challenge},
  journal = {Transfusion},
  year = {2026},
  volume = {66},
  number = {7},
  pages = {1444--1448},
  doi = {10.1111/trf.70222}
}
Kostenlos starten →